Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1

JOURNAL ARTICLE published 3 April 2017 in Expert Opinion on Therapeutic Patents

Research funded by National Natural Science Foundation of China (81273354,81573347) | Science and Technology Development Project of Shandong Province (2014GSF118012,2014GSF118175) | Young Scholars Program of Shandong University (YSPSDU) | Key Project of NSFC for International Cooperation (30910103908,81420108027) | Major Project of Science and Technology of Shandong Province (2015ZDJS04001)

Authors: Dongwei Kang | Zhipeng Huo | Gaochan Wu | Jiabao Xu | Peng Zhan | Xinyong Liu

New developments around histamine H₃receptor antagonists/inverse agonists: a patent review (2010 – present)

JOURNAL ARTICLE published January 2014 in Expert Opinion on Therapeutic Patents

Authors: Dorota Łażewska | Katarzyna Kieć-Kononowicz

Protein kinase C inhibitors: a patent review (2008 – 2009)

JOURNAL ARTICLE published October 2013 in Expert Opinion on Therapeutic Patents

Authors: M Elizabeth Sobhia | Baljinder K Grewal | Stanly Paul ML | Jigneshkumar Patel | Amandeep Kaur | Thongtinlal Haokip | Alekhya Kokkula

Inhibitors of cathepsin K: a patent review (2004 – 2010)

JOURNAL ARTICLE published October 2011 in Expert Opinion on Therapeutic Patents

Authors: Jac Wijkmans | Jan Gossen

Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature

JOURNAL ARTICLE published 1 December 2016 in Expert Opinion on Therapeutic Patents

Research funded by National Institutes of Health (NIH AI117224)

Authors: Graham S. Timmins

Inhibitors of human neutrophil elastase as a potential treatment for inflammatory diseases

JOURNAL ARTICLE published July 1999 in Expert Opinion on Therapeutic Patents

Authors: William A Metz | Norton P Peet

JOURNAL ISSUE published March 2003 in Expert Opinion on Therapeutic Patents

Annotated Patent Selections

JOURNAL ARTICLE published December 2006 in Expert Opinion on Therapeutic Patents

HMG-CoA inhibitors for the treatment of cancer

JOURNAL ARTICLE published September 1994 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published June 2007 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published April 2005 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published January 2006 in Expert Opinion on Therapeutic Patents

Novel therapeutic strategies for impaired endothelium-dependent vascular relaxation

JOURNAL ARTICLE published August 2002 in Expert Opinion on Therapeutic Patents

Authors: Rui Wang | Joseph Fomusi Ndisang

A patent review of adenosine A_2Breceptor antagonists (2016-present)

JOURNAL ARTICLE published 3 June 2022 in Expert Opinion on Therapeutic Patents

Authors: Beatrice Francucci | Diego Dal Ben | Catia Lambertucci | Andrea Spinaci | Rosaria Volpini | Gabriella Marucci | Michela Buccioni

Monoclonal antibody–drug conjugates

JOURNAL ARTICLE published September 2005 in Expert Opinion on Therapeutic Patents

Authors: Philip R Hamann

Small molecules as activators in medicinal chemistry (2000–2016)

JOURNAL ARTICLE published 3 October 2017 in Expert Opinion on Therapeutic Patents

Research funded by Higher Education Commission, Pakistan (20-1910)

Authors: Abdul Hameed | Mariya Al-Rashida | Rima D. Alharthy | Maliha Uroos | Ehsan Ullah Mughal | Syed Abid Ali | Khalid Mohammed Khan

Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016)

JOURNAL ARTICLE published 4 May 2017 in Expert Opinion on Therapeutic Patents

Authors: Simona Collina | Emanuele Bignardi | Marta Rui | Daniela Rossi | Raffaella Gaggeri | Alice Zamagni | Michela Cortesi | Anna Tesei

Analysis of patents on anti-gout therapies issued in China

JOURNAL ARTICLE published May 2014 in Expert Opinion on Therapeutic Patents

Authors: Hong-Yu Yuan | Xue-Hui Zhang | Xiao-Lan Zhang | Ji-Fu Wei | Ling Meng

Dopamine D3 receptor antagonists: a patent review (2007 – 2012)

JOURNAL ARTICLE published March 2013 in Expert Opinion on Therapeutic Patents

Authors: Fabrizio Micheli | Christian Heidbreder

Protein tyrosine kinase inhibitors as anticancer agents

JOURNAL ARTICLE published January 2004 in Expert Opinion on Therapeutic Patents

Authors: Claudiu T Supuran | Andrea Scozzafava